Access And Reimbursement For Emerging Neuropathic Pain Agents In The EU5- Avoiding The Sting Of Low-Cost Competition And Tightening Budgets
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.939
https://www.valueinhealthjournal.com/article/S1098-3015(17)31273-1/fulltext
Title :
Access And Reimbursement For Emerging Neuropathic Pain Agents In The EU5- Avoiding The Sting Of Low-Cost Competition And Tightening Budgets
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)31273-1&doi=10.1016/j.jval.2017.08.939
First page :
A564
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
894